American Society of Gene & Cell Therapy

06/17/2026

OMB has proposed significant changes to the federal grantmaking framework, including provisions affecting peer review, international collaboration, and scientific communication. Read more in the latest Advocate: https://www.asgct.org/advocacy/the-advocate-newsletter/the-advocate-june-2026

OMB has proposed significant changes to the federal grantmaking framework, including provisions affecting peer review, international collaboration, and…

06/17/2026

While AAV and LNPs continue to revolutionize the field of genomic medicine, translating these powerful delivery platforms into safe, predictable, and scalable clinical therapies presents unique challenges.

To bridge the gap between preclinical innovation and clinical reality, we're excited to partner with the Clinical In Vivo Gene Therapy (CIGT) group of the Children's Hospital of Philadelphia for this comprehensive, one-day event: https://www.asgct.org/events-meetings/safety-translation-and-real-world-implementation-of-aav-and-lnp-gene-therapies

06/16/2026

📢 Calling all CGT early-stage investigators! The Emily Whitehead Foundation is providing a $50,000 funding opportunity to US-based early-stage investigators advancing novel pediatric cell and gene therapies.

Submissions are open now and close on June 30. Learn more and apply: https://www.emilywhiteheadfoundation.org/grants/

Submissions are still open for the Nicole Gularte "Fight for Cures" Embassador Award!

Created in honor of leukemia patient advocate and CAR T-cell therapy Warrior Nicole Gularte, this award supports the next generation of researchers advancing cellular-based pediatric cancer treatments. Nicole inspired countless families with her strength, advocacy, and unwavering mission to “fight for cures,” and her legacy continues through this important research initiative.

The selected recipient will receive a $50,000 research grant funded in collaboration with our friends at Cytiva at the Foundation’s now annual Believe Ball to help advance innovative work in pediatric immunotherapy and cellular therapies. Eligible candidates are reviewed by a committee made up of Nicole’s peers, family members, and experts in the field.

Submit a proposal and learn more: https://www.emilywhiteheadfoundation.org/grants/

06/16/2026

When you join ASGCT, you become part of a worldwide network of innovators driven by a common goal: advancing scientific research to shape the future of cell and gene therapy.

ASGCT members are pioneers driven by a commitment to collaboration, professional growth and meaningful impact.

Join our network and become a member today: asgct.org/become-a-member

06/16/2026

How has ASGCT membership shaped a career in regulatory policy? Hear from Dylan Bechtle, Director of Regulatory Policy in North America at Johnson & Johnson. Dylan shares how the ASGCT community and resources have been invaluable for navigating the fast-moving cell and gene therapy space.

🎧 Listen now: https://www.asgct.org/education-career-resources/media-library/member-minutes-dylan-bechtle

06/12/2026

It's never been easier to start building your foundational knowledge of CGT! Our Foundations of Cell & Gene Therapy online course is:
✔️ 100% free
✔️ Entirely self-paced
✔️ Led by field experts

Choose a module and start learning today: https://www.asgct.org/education-career-resources/asgct-learning-center

06/04/2026

Designed specifically for the next generation of medical leaders, this focused, one-day program provides the critical insights needed to navigate the rapidly evolving clinical landscape of cell and gene therapies.

Learn more and register: asgct.org/gme

06/04/2026

Our premier policy event is returning to Washington, D.C.!

Join us on September 14 to connect directly with key decision-makers, advocate for the field, and drive the critical conversations shaping the future of cell and gene therapy.

Space is limited – secure your spot today: asgct.org/policysummit

06/02/2026

New ASGCT member Dr. Mark Deehan (Massachusetts General Hospital) discusses how his ASGCT Career Development Award, funded by the Foundation for Angelman Syndrome Therapeutics, is fueling new progress in his lab's research.

🎧 Listen now: https://www.asgct.org/education-career-resources/media-library/member-minutes-mark-deehan-phd

06/01/2026

Ready to take your research to the next level? Early-career researchers and emerging investigators can secure a $100,000 grant to fund independent pilot studies or advance their professional development in cell and gene therapy.

Don't miss this opportunity to fuel your science and your career. Join ASGCT and apply today!

✔️ Career Development Award: asgct.org/cda
✔️ Expanding Pathways Fellowship: asgct.org/expanding